Home treatment of COPD exacerbations

Thorax

Volumn 54, Issue SUPPL. 2, 1999, Pages

  Postma, Dirkje S ^a   Hacken, Nick H T Ten ^a   Kerstjens, Huib A M ^a   Koëter, Gerard H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOME CARE; HOSPITAL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MORTALITY; NURSING; OXYGEN SATURATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0032809096     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.2008.s8     Document Type: Review

References (39)

1. 1 Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
2. 2 Collet JP, Shapiro S, Ernst P, et al. Effect of an immunostimulating agent on acute exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1719-24.
3. 3 Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
4. 4 Angus RM, Murray S, Lay JW, et al. Management of chronic airflow obstruction: differences in practice between respiratory and general physicians. Thorax 1994;88:493-7.
5. 5 Connors AF, Dawson NV, Thomas C, et al. Outcome following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959-67.
6. 6 Gravil JH, Al-Rawas OA, Cotton MM, et al. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet 1998;351:1853-5.
7. 7 American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: ATS statement. Am J Respir Crit Care Med 1995;152:S77-S120.
8. 8 Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Society. Eur Respir J 1995;8:1398-120.
9. 9 Thompson WH, Nielson CP, Carvalho P, et al. Controlled clinical trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12.
10. 10 Connors AF, Dawson NW, Thomas C, et al for the SUPPORT Investigators. Outcome following acute exacerbations of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959-67.
11. 11 Hagedorn SD. Acute exacerbations of COPD. How to evaluate severity and treat the underlying cause. Postgrad Med 1992;91:105-12.
12. 12 Sachs AP, Koëter GH, Groenier KG, et al. Changes in symptoms, peak expiratory flow and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995;50:758-63.
13. 13 Fletcher CM, Peto R, Tinker C, et al. The natural history of chronic bronchitis and emphysema: an eight year study of early chronic obstructive lung disease in working men in London. New York: Oxford University Press, 1976: 272.
14. 14 Wilson R, Dowling RB, Jackson AD. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respir J 1996; 9:1523-30.
15. 15 Schlick W. Selective indications for use of antibiotics: when and what? Eur Respir Rev 1992;9:187-92.
16. 16 Rothbarth PH, Kempen BM, Sprenger JW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:1682-6.
17. 17 Zalacain R, Sobradillo V, Amilibia J, et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1998;13:343-8.
18. 18 Wilson R. Bacterial infection and chronic obstructive pulmonary disease. Eur Respir J 1998;13:233-5.
19. 19 Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273: 957-60.
20. 20 Siafakas NM, Bouros D. Management of acute exacerbation of chronic obstructive pulmonary disease. In: Management of chronic obstructive pulmonary disease, A European Respiratory Monograph. Vol 3. 1998: 264-277.
21. 21 Stedman JR, Anderson HR, Atkinson RW, et al. Emergency hospital admissions for respiratory disorders attributable to summer time ozone episodes in Great Britain. Thorax 1997;52:958-63.
22. 22 Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990;11:555-69.
23. 23 Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994;150:1646-52.
24. 24 Osman LM, Godden DJ, Friend JAR, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997;52:67-71.
25. 25 Petty TL. Long-term outpatient oxygen-therapy. In: Petty TL, ed. Chronic obstructive pulmonary disease. New York: Marcel Dekker, 1985: 375-88.
26. 26 Vitacca M, Clini E, Porta R, et al. Acute exacerbation in patients with COPD: predictors of need for mechanical ventilation. Eur Respir J 1996;9:1487-93.
27. 27 Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158-64.
28. 28 Costello R, Deagen P, Fitzpatrick M, et al. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997;102:239--44.
29. 29 Leger P, Bedicam JM, Cornette A, et al. Nasal intermittent positive pressure ventilation: long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994;105:100-5.
30. 30 Clini E, Vitaca M, Foglio K, et al. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 1996;9:1605-10.
31. 31 Seemungal TAR, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
32. 32 Traver GA. Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airway disease. Heart Lung 1988;17:689-97.
33. 33 Cox NJ, Hendricks JC, Binkhorst RA, et al. A pulmonary rehabilitation program for patients with asthma and mild chronic obstructivce pulmonary diseases (COPD). Lung 1993;171:235-44.
34. 34 Rice KL, Leatherman JW, Duane PG, et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;107:305-9.
35. 35 Paggiaro PL, Dahle R, Bakran L, et al. Multicenter randomized placebo controlled trial of inhaled fluticasone propionate in patients with COPD. Lancet 1998;351:773-80.
36. 36 Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995;8:1333-8.
37. 37 Tougaard L, Krone T, Sorknaes A, et al and the PASTMA group. Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. Lancet 1992;339:1517-20.
38. 38 Van der Schans CP, Piers DA, Beekhuis H, et al. Effect of forced expirations on mucus clearance in patients with chronic airflow obstruction; effect of lung recoil pressure. Thorax 1990;45:623-7.
39. 39 Sportel JH, Koëter GH, Van Altena R, et al. Relation between betalactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD). Thorax 1995;50:249-53.